Phlorizin vs Phloretin: Glycoside-Aglycone Relationship

Written and reviewed by Dr. Xiaoyan Qiu · July 2026

Phlorizin and Phloretin: The Glycoside–Aglycone Relationship

Phloretin and phlorizin are the same dihydrochalcone core structure in two different chemical states. Phloretin is the aglycone; phlorizin is its glucose-bound form, produced when a glucose molecule is attached at the 2′ position of the phloretin backbone. The two interconvert in both directions: phlorizin hydrolyzes to the aglycone and glucose under aqueous or enzymatic conditions, while in the apple plant itself the reverse reaction also occurs — a specific glycosyltransferase enzyme (MdPGT1) glycosylates the aglycone using UDP-glucose to biosynthesize phlorizin in planta, a pathway confirmed through gene isolation work in Malus domestica.^[1] This bidirectional relationship means the two compounds are rarely found in complete isolation from one another in raw plant material — any given batch of crude extract typically contains a mixture of both, with the ratio depending on tissue type, processing conditions, and extraction method. For the full structural, historical, and sourcing profile of the glucoside form specifically, see our companion article, Phlorizin: Structure, Natural Sources, and Industrial Extraction.

Because the two compounds share the same core skeleton, they also share plant sources — anywhere phlorizin occurs naturally, its aglycone is typically present as well, either as a co-occurring free compound or as a byproduct of in-plant or in-process hydrolysis. This includes apple root bark and, as covered in our companion piece on Lithocarpus litseifolius extract, the sweet tea plant whose phytochemical profile spans trilobatin, phlorizin, and phloretin across different tissue and maturity stages. For B2B buyers, this co-occurrence is a practical reason to request a full compound breakdown rather than a single-marker assay when evaluating a new supplier’s crude extract, since a “phlorizin extract” and a “phloretin extract” from the same raw material source may differ mainly in how far the hydrolysis reaction was allowed to proceed during processing, not in which plant they came from.

What Is Phloretin? Structure and Properties

Phloretin’s molecular formula is C₁₅H₁₄O₅, with a molecular weight of approximately 274.3 g/mol — roughly 160 g/mol lighter than phlorizin, reflecting the absence of the glucose unit. Structurally, it consists of two aromatic rings connected by a three-carbon α,β-unsaturated carbonyl chain, with hydroxyl groups positioned at 2′, 4, 4′, and 6′.^[2] As the aglycone member of the dihydrochalcone family, it shares its broader classification with phlorizin but is treated as a structurally and functionally distinct ingredient in its own right within the research literature.^[5]

In appearance, this compound is a white to pale yellow crystalline powder. Its defining practical difference from the glucoside form is solubility: without a glucose moiety to improve hydrophilicity, it has markedly limited solubility in water, while dissolving more readily in organic solvents such as ethanol, methanol, and DMSO. This solubility profile is the single most important variable formulators need to account for when choosing between the two forms — a distinction covered in detail in the next section. It is also the reason batch handling differs between the two: phloretin extract is typically processed and stored under conditions that avoid prolonged aqueous suspension, since re-dissolving it fully in water-based systems generally requires co-solvents, surfactants, or elevated temperature.

Solubility and Stability: Why Form Matters for Formulators

Phlorizin’s glucose unit makes it substantially more compatible with aqueous formulation systems — water-based beverages, tablet-compatible powder blends, and toner-type cosmetic bases. Its aglycone, by contrast, behaves more like a lipophilic active: poor water solubility but good compatibility with oil-phase, alcohol-based, or emulsified delivery systems. Formulators moving between the two compounds for the first time sometimes assume they are interchangeable at equivalent weight percentages simply because they are structurally related; in practice, the solubility gap means a formula built around one form usually needs to be re-worked, not just re-labeled, if switched to the other.

This lipophilicity is not simply a formulation inconvenience — it is directly tied to a documented ability to modify skin barrier behavior. In controlled human skin permeation studies, pre-treatment with this compound increased the cumulative percutaneous absorption of a model drug compound by up to 3.2-fold under acidic pH conditions, an effect attributed to its influence on the membrane dipole potential of the skin’s lipid bilayers.^[3] The proposed mechanism involves the compound altering the internal dipole potential across the lipid bilayer, which in turn changes how readily other charged or polar molecules can cross the stratum corneum. This is one reason the aglycone form is of specific interest to cosmetic formulators building penetration-enhancing serum systems, distinct from phlorizin’s more straightforward role as a water-soluble antioxidant additive.

On stability, this compound has an advantage in one specific sense: because it is already the aglycone, it has no glucose unit left to hydrolyze off, removing one degradation pathway that phlorizin-based formulations need to manage in humid or aqueous storage conditions. The trade-off is that its own stability concerns shift toward oxidation of the free phenolic hydroxyl groups rather than hydrolytic breakdown, which is why antioxidant-grade material is generally packaged under inert atmosphere or with light-protective packaging for extended shelf life.

Phloretin in Cosmetic Formulation: Antioxidant Applications

This compound’s radical-scavenging capacity has been measured directly against two conventional synthetic antioxidants used in cosmetic preservation. In a DPPH radical inhibition assay, it returned an EC50 of 24.5 µM, indicating stronger antioxidant activity than BHT (EC50 28 µM) and moderately weaker activity than BHA (EC50 18.5 µM) — placing it competitively among both synthetic and natural antiradical agents evaluated in the same study.^[2] This comparison matters commercially because BHA and BHT are increasingly scrutinized as potential endocrine disruptors in cosmetic formulation, giving plant-derived alternatives with comparable radical-scavenging performance a clear positioning argument for brands moving toward “clean” antioxidant systems.

Researchers attribute part of this compound’s antioxidant and anti-tyrosinase performance specifically to its free hydroxyl group at the 2′ position — a site that is blocked by the glucose unit in phlorizin. This structural difference is a practical reason formulators sometimes select the aglycone over the glucoside for antioxidant-positioned skincare formats such as serums and brightening treatments, where the unglycosylated form’s reactivity profile is the more relevant property, rather than the aqueous solubility that favors phlorizin in food or beverage systems. Anti-tyrosinase activity, tested in the same structural comparison work, is a separate but related property: it inhibits the enzyme responsible for melanin production, which is the mechanistic basis for its use in hyperpigmentation-focused formulations rather than general-purpose antioxidant positioning alone.

Sourcing Phlorizin vs Phloretin: Which Form for Your Application

The choice between the two forms follows directly from the solubility and reactivity differences above. For food, beverage, and dietary supplement applications, phlorizin’s water solubility and its status as a naturally occurring apple-derived glucoside generally make it the more straightforward fit — full detail is available in our phlorizin sourcing article. For antioxidant-positioned cosmetic serums and penetration-enhancing formulations, the aglycone’s lipophilicity and unblocked hydroxyl group are typically the deciding factors. A smaller number of formulations use both forms deliberately in combination — a water-soluble phlorizin base for general antioxidant coverage, paired with a lower-inclusion phloretin component specifically for its penetration-enhancing effect on other actives in the same formula.

Whichever form a formulation calls for, purity verification should confirm the target compound specifically rather than relying on total dihydrochalcone content — UHPLC-ESI-MS/MS methods capable of resolving phlorizin and phloretin in the same sample run are the standard way to confirm a batch has not partially hydrolyzed or under-hydrolyzed relative to its labeled form.^[4] This matters most for buyers sourcing either compound from processors who also produce the other, since shared processing lines and equipment carry some risk of cross-contamination between forms unless batch-specific verification is requested as a standard practice rather than an occasional spot-check. Valeherb supplies both compounds at 98% purity by HPLC, each with batch-specific certificates of analysis: bulk phlorizin powder and bulk phloretin powder.

Frequently Asked Questions

References